
Atlantic Sapphire reported an 87% revenue increase in 2025, rising from $23 million to over $43 million due to higher production volume and premium pricing. Operational improvements were seen across key performance indicators, including stable biology and increased production parameters. However, the company faces financial challenges in 2026, prompting a $10 million bridge loan to sustain operations until reaching EBITDA breakeven. Efforts continue to improve feed conversion efficiency, a critical operational metric linked to ongoing biofiltration and degassing projects.